Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Loss of Mecp2 in substantia nigra dopamine neurons compromises the nigrostriatal pathway.

Gantz SC, Ford CP, Neve KA, Williams JT.

J Neurosci. 2011 Aug 31;31(35):12629-37. doi: 10.1523/JNEUROSCI.0684-11.2011.

2.

Impaired hippocampal Ca2+ homeostasis and concomitant K+ channel dysfunction in a mouse model of Rett syndrome during anoxia.

Kron M, Müller M.

Neuroscience. 2010 Nov 24;171(1):300-15. doi: 10.1016/j.neuroscience.2010.08.031. Epub 2010 Aug 21.

PMID:
20732392
3.

Morphological and functional alterations in the substantia nigra pars compacta of the Mecp2-null mouse.

Panayotis N, Pratte M, Borges-Correia A, Ghata A, Villard L, Roux JC.

Neurobiol Dis. 2011 Feb;41(2):385-97. doi: 10.1016/j.nbd.2010.10.006. Epub 2010 Oct 14.

PMID:
20951208
4.

MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome.

Kao FC, Su SH, Carlson GC, Liao W.

Brain Struct Funct. 2015 Jan;220(1):419-34. doi: 10.1007/s00429-013-0664-x. Epub 2013 Nov 12.

PMID:
24218106
5.

A mouse juvenile or adult slice with preserved functional nigro-striatal dopaminergic neurons.

Ammari R, Lopez C, Fiorentino H, Gonon F, Hammond C.

Neuroscience. 2009 Mar 3;159(1):3-6. doi: 10.1016/j.neuroscience.2008.10.051. Epub 2008 Nov 7.

PMID:
19032976
6.

Excitation/inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout mice.

Calfa G, Li W, Rutherford JM, Pozzo-Miller L.

Hippocampus. 2015 Feb;25(2):159-68. doi: 10.1002/hipo.22360. Epub 2014 Sep 25.

7.

Anatomical and electrophysiological changes in striatal TH interneurons after loss of the nigrostriatal dopaminergic pathway.

Ünal B, Shah F, Kothari J, Tepper JM.

Brain Struct Funct. 2015 Jan;220(1):331-49. doi: 10.1007/s00429-013-0658-8. Epub 2013 Oct 31.

8.

The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.

Chang Q, Khare G, Dani V, Nelson S, Jaenisch R.

Neuron. 2006 Feb 2;49(3):341-8.

9.

Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors.

Anzalone A, Lizardi-Ortiz JE, Ramos M, De Mei C, Hopf FW, Iaccarino C, Halbout B, Jacobsen J, Kinoshita C, Welter M, Caron MG, Bonci A, Sulzer D, Borrelli E.

J Neurosci. 2012 Jun 27;32(26):9023-34. doi: 10.1523/JNEUROSCI.0918-12.2012.

10.

A critical and cell-autonomous role for MeCP2 in synaptic scaling up.

Blackman MP, Djukic B, Nelson SB, Turrigiano GG.

J Neurosci. 2012 Sep 26;32(39):13529-36.

11.

Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.

Kozina EA, Khakimova GR, Khaindrava VG, Kucheryanu VG, Vorobyeva NE, Krasnov AN, Georgieva SG, Kerkerian-Le Goff L, Ugrumov MV.

J Neurol Sci. 2014 May 15;340(1-2):198-207. doi: 10.1016/j.jns.2014.03.028. Epub 2014 Mar 21.

PMID:
24768159
12.

Loss of MeCP2 function is associated with distinct gene expression changes in the striatum.

Zhao YT, Goffin D, Johnson BS, Zhou Z.

Neurobiol Dis. 2013 Nov;59:257-66. doi: 10.1016/j.nbd.2013.08.001. Epub 2013 Aug 13.

13.

Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway.

Wu N, Joshi PR, Cepeda C, Masliah E, Levine MS.

J Neurosci Res. 2010 Jun;88(8):1764-76. doi: 10.1002/jnr.22327.

14.

Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.

Okabe Y, Kusaga A, Takahashi T, Mitsumasu C, Murai Y, Tanaka E, Higashi H, Matsuishi T, Kosai K.

Brain Res. 2010 Nov 11;1360:17-27. doi: 10.1016/j.brainres.2010.08.090. Epub 2010 Sep 25.

PMID:
20816763
15.

Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome.

Taneja P, Ogier M, Brooks-Harris G, Schmid DA, Katz DM, Nelson SB.

J Neurosci. 2009 Sep 30;29(39):12187-95. doi: 10.1523/JNEUROSCI.3156-09.2009.

16.

Time-dependent modulation of GABA(A)-ergic synaptic transmission by allopregnanolone in locus coeruleus neurons of Mecp2-null mice.

Jin X, Zhong W, Jiang C.

Am J Physiol Cell Physiol. 2013 Dec 1;305(11):C1151-60. doi: 10.1152/ajpcell.00195.2013. Epub 2013 Sep 25.

17.

Postnatal changes in serotonergic innervation to the hippocampus of methyl-CpG-binding protein 2-null mice.

Isoda K, Morimoto M, Matsui F, Hasegawa T, Tozawa T, Morioka S, Chiyonobu T, Nishimura A, Yoshimoto K, Hosoi H.

Neuroscience. 2010 Feb 17;165(4):1254-60. doi: 10.1016/j.neuroscience.2009.11.036. Epub 2009 Nov 22.

PMID:
19932741
18.

Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function.

Abdallah L, Bonasera SJ, Hopf FW, O'Dell L, Giorgetti M, Jongsma M, Carra S, Pierucci M, Di Giovanni G, Esposito E, Parsons LH, Bonci A, Tecott LH.

J Neurosci. 2009 Jun 24;29(25):8156-65. doi: 10.1523/JNEUROSCI.3905-08.2009.

19.

MeCP2 in the rostral striatum maintains local dopamine content critical for psychomotor control.

Su SH, Kao FC, Huang YB, Liao W.

J Neurosci. 2015 Apr 15;35(15):6209-20. doi: 10.1523/JNEUROSCI.4624-14.2015.

20.

Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation.

Belichenko NP, Belichenko PV, Mobley WC.

Neurobiol Dis. 2009 Apr;34(1):71-7. doi: 10.1016/j.nbd.2008.12.016. Epub 2009 Jan 8.

PMID:
19167498
Items per page

Supplemental Content

Write to the Help Desk